title: Protective effects of baicalein and wogonin against benzo[a]pyrene- and aflatoxin B(1)-induced genotoxicities.
abstract: To evaluate the protective effects of baicalein and wogonin against benzo[a]pyrene- and aflatoxin (AF) B(1)-induced toxicities, the effects of these flavonoids on the genotoxicities and oxidation of benzo[a]pyrene and AFB(1) were studied in C57BL/6J mice. Baicalein and wogonin reduced benzo[a]pyrene and AFB(1) genotoxicities as monitored by the umuC gene expression response in Salmonella typhimurium TA1535/pSK1002. Baicalein added in vitro decreased liver microsomal benzo[a]pyrene hydroxylation (AHH) activity with an ic(50) of 33.9 +/- 1.4 microM at 100 microM benzo[a]pyrene. Baicalein also inhibited AFQ(1) and AFB(1)-epoxide formation from AFB(1) (50 microM) oxidation (AFO) with ic(50) values of 22.8 +/- 1.4 and 5.3 +/- 0.8 microM, respectively. However, the in vitro inhibitory effects of wogonin on AHH and AFO activities in liver microsomes were less than those of baicalein as inhibition by 500 microM wogonin was only about 51-65%. Treatment of mice with liquid diets containing 5 mM baicalein and wogonin resulted in 22 and 49% decreases in hepatic AHH activities, respectively. Baicalein treatment resulted in 39 and 32% decreases in AFQ(1) and AFB(1)-epoxide formation from liver microsomal AFO, respectively. Wogonin treatment resulted in 39 and 47% decreases in AFQ(1) and AFB(1)-epoxide formation, respectively. A 1-week pretreatment with wogonin significantly decreased hepatic DNA adduct formation in mice treated with 200 mg/kg of benzo[a]pyrene via gastrogavage. These in vitro and in vivo effects suggested that baicalein and wogonin might have beneficial effects against benzo[a]pyrene- and AFB(1)-induced hepatic toxicities and that wogonin had a stronger protective effect in vivo.
authors.affiliation: National Research Institute of Chinese Medicine, 155-1, Li-Nong Street, Sec. 2, 112, ROC, Taipei, Taiwan. ueng@cma23.nricm.edu.tw
authors.forename: Y F
authors.initials: YF
authors.lastname: Ueng
authors.forename: C C
authors.initials: CC
authors.lastname: Shyu
authors.forename: T Y
authors.initials: TY
authors.lastname: Liu
authors.forename: Y
authors.initials: Y
authors.lastname: Oda
authors.forename: Y L
authors.initials: YL
authors.lastname: Lin
authors.forename: J F
authors.initials: JF
authors.lastname: Liao
authors.forename: C F
authors.initials: CF
authors.lastname: Chen
mesh_terms: D016604:Aflatoxin B1 / Q000633:toxicity*; D000818:Animals; D001564:Benzo(a)pyrene / Q000633:toxicity*; D004032:Diet; D004347:Drug Interactions; D044950:Flavanones; D005419:Flavonoids / Q000494:pharmacology*; D006900:Hydroxylation; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008862:Microsomes, Liver / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D009152:Mutagenicity Tests; D009251:NADPH-Ferrihemoprotein Reductase / Q000187:drug effects / Q000378:metabolism; D020011:Protective Agents / Q000494:pharmacology*
chemical_list: D044950:Flavanones; D005419:Flavonoids; D020011:Protective Agents; D001564:Benzo(a)pyrene; C006680:baicalein; D016604:Aflatoxin B1; D009251:NADPH-Ferrihemoprotein Reductase; C085514:wogonin